Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-019968
Filing Date
2018-07-17
Accepted
2018-07-17 20:44:35
Documents
1
Period of Report
2018-07-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5073
  Complete submission text file 0000899243-18-019968.txt   6454
Mailing Address C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT NOVATO CA 94949
Business Address
Fust Matthew K (Reporting) CIK: 0001397266 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38583 | Film No.: 18957549

Mailing Address 6197 CORNERSTONE COURT, SUITE 111 SAN DIEGO CA 92121
Business Address 6197 CORNERSTONE COURT, SUITE 111 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Issuer) CIK: 0001658247 (see all company filings)

EIN.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations